| 000 | 02494nam a22003375i 4500 | ||
|---|---|---|---|
| 999 |
_c399346 _d399346 |
||
| 001 | 399346 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240415151942.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230901s2023 sz | o |||| 0|eng d | ||
| 020 | _a9783031400476 | ||
| 024 | 7 |
_a10.1007/978-3-031-40047-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRM301.3 .G45 _b2023 EB |
|
| 245 | 0 | 0 |
_aPrecision Medicine _cedited by Ingolf Cascorbi, Matthias Schwab |
| 250 | _a1st ed. 2023 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2023 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aHandbook of Experimental Pharmacology _x1865-0325 _v280 |
|
| 505 | 0 | _aPart 1. Pharmacogenomics -- Building evidence in RCTs Implementation of pharmacogenomics in healthcare in the UK -- Part 2. Precision medicine in clinical entities -- Precision medicine in therapy of non-solid cancer -- Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia -- Precision medicine in Asthma -- Precision medicine in Diabetes -- Precision Medicine in Antidepressants Treatment -- Precision Medicine in Neuropathic Pain -- Part 3. Techniques in Precision Medicine -- Imaging techniques in pharmacological precision medicine -- Challenges to use NGS data to optimize drug therapy -- Part 4. Economics -- Pharmacoeconomics in precision medicine. . | |
| 520 | _aThe rapidly increased understanding of the molecular background of complex diseases facilitated the development of highly advanced therapeutic concepts. Such concepts aiming to consider individual signatures of genomic and proteomic biomarkers including pharmacogenomics as well as advanced diagnostic tools have been successfully implemented in clinical practice in various fields leading to significant improvement of treatment successes. This volume gives an up-to-date overview on applications of precision medicine in various clinical entities, on advanced techniques as well as on economic considerations. | ||
| 988 | _aSpringer_BiomedLife_2023 | ||
| 650 | 7 |
_2embne _9165192 _aFarmacogenómica |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-40047-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b04/2024 _dz _eb _zSI |
||